Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms.
about
Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based ProteomicsEfficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4.Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach.Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer.A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion.Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer.Proteomics approach to identify biomarkers for upper gastrointestinal cancer.Reevaluation of Pholiota squarrosa lectin-reactive haptoglobin as a pancreatic cancer biomarker using an improved ELISA systemMetabolomic biomarkers of pancreatic cancer: a meta-analysis study.Recent advances in proteomic profiling of pancreatic ductal adenocarcinoma and the road ahead.Proteomic biomarkers in body fluids associated with pancreatic cancer.Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics.Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma.
P2860
Q36118351-C95AB83E-0E9F-4047-AAD6-A5D3014F2F9CQ37362867-98741A6D-B9E1-41D0-A1C9-7150E101B93DQ38780454-4993A71F-BA09-40D2-A957-AED9A2B8EAB5Q38815842-2D22DB36-1D0D-4057-8405-DA60B3C6D525Q38868263-85EAE32F-7D7F-4A8F-92E3-BA38F37BAEC0Q38965713-E5908AD0-5C23-46EE-B32E-D13F23496F41Q38975703-708534DE-CE72-4F4F-9AF8-32F3CF7975C2Q40962674-7F07B57E-303A-4BCB-B3CD-A865CE9D02CDQ42154484-D3363ADE-62C8-4175-B5FB-31AAB85276A9Q47659096-05F5E6E4-001A-414D-B5DA-832BD2C36AA5Q52584324-84378450-9AD2-46DD-AC25-C82D04904AC7Q54977145-3B6A77D1-2249-4B52-88D3-2336A3C3217EQ55445091-7B84636F-E2D6-4852-A2F8-1DE77BF58CD9
P2860
Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Plasma biomarker for detection ...... r apolipoprotein-AII isoforms.
@ast
Plasma biomarker for detection ...... r apolipoprotein-AII isoforms.
@en
type
label
Plasma biomarker for detection ...... r apolipoprotein-AII isoforms.
@ast
Plasma biomarker for detection ...... r apolipoprotein-AII isoforms.
@en
prefLabel
Plasma biomarker for detection ...... r apolipoprotein-AII isoforms.
@ast
Plasma biomarker for detection ...... r apolipoprotein-AII isoforms.
@en
P2093
P2860
P356
P1433
P1476
Plasma biomarker for detection ...... r apolipoprotein-AII isoforms.
@en
P2093
Akihiko Tsuchida
Giman Jung
Hirokazu Shoji
Jo Ann Rinaudo
Kazufumi Honda
Masahiro Kamita
Masashi Shimahara
Michimoto Kobayashi
Mitsuaki Sanada
Nami Miura
P2860
P2888
P356
10.1038/SREP15921
P407
P577
2015-11-09T00:00:00Z